Elisabeth Groß

6PUBLICATIONS

16CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersHaematological tumoursGene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jul 06, 2026

Retroperitoneal bulk predicts chylothorax in follicular lymphoma-control requires systemic response.

|Jul 14, 2023

Palladium and Platinum Complexes of the Antimetabolite Fludarabine with Vastly Enhanced Selectivity for Tumour over Non-Malignant Cells.

Sebastian W Schleser, Oleksandr Krytovych, Tim Ziegelmeier

|Jun 10, 2023

SAM-Competitive EZH2-Inhibitors Induce Platinum Resistance by EZH2-Independent Induction of ABC-Transporters.

Elisabeth Groß, Ralf-Axel Hilger, Franziska Lea Schümann

|Dec 24, 2021

Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas.

Franziska Lea Schümann, Elisabeth Groß, Marcus Bauer

|Oct 13, 2021

RBMX Protein Expression in T-Cell Lymphomas Predicts Chemotherapy Response and Prognosis.

Franziska Lea Schümann, Marcus Bauer, Elisabeth Groß

|Jun 02, 2021

BRAF/EZH2 Signaling Represses miR-129-5p Inhibition of SOX4 Thereby Modulating BRAFi Resistance in Melanoma.

Kathleen Gebhardt, Bayram Edemir, Elisabeth Groß

Pageof 1

Frequent Collaborators

Thomas Weber

Marcus Bauer

Andreas Wienke

Thomas Mueller

Cord Sunderkötter

Sarah Sandmann

Martin Dugas

Edith Willscher

Jana Lützkendorf

Mascha Binder

Frequent Collaborators

Thomas Weber

Marcus Bauer

Andreas Wienke

Thomas Mueller